Dalrada Corporation’s Pala Diagnostics Free COVID-19 Point-of-care Tests Proved Compliance for Nearly 3,000 Outdoor Festival Attendees
Dalrada Corporation (OTCQB: DFCO) has announced its community outreach initiative providing free COVID-19 point-of-care tests at events, including the Boise Pride Festival. Pala Diagnostics, a joint venture with Vivera Pharmaceuticals, administered nearly 3,000 rapid antigen and PCR tests, ensuring compliance with health protocols. The collaboration aims to restore safe public gatherings, reflecting the company's commitment to innovative health solutions. As part of its strategy, Dalrada focuses on disruptive solutions across its business divisions to address global challenges.
- Successful administration of nearly 3,000 COVID-19 tests at the Boise Pride Festival, showcasing operational capability.
- Collaboration with community events emphasizes Dalrada's commitment to public health and safety.
- Pala Diagnostics offers rapid results within 24 hours for PCR testing, enhancing service efficiency.
- None.
To ensure the health and safety of its guests, event coordinators required all attendees, volunteers, performers, and staff to show proof of COVID-19 immunization or a negative PCR or antigen test. All recipients of Pala Diagnostics’ HIPAA compliant test results received a text message to retrieve evidence of COVID-19 testing. All who provided valid proof received an event health check wristband before entry into the festival.
Dalrada continuously builds on its core practices of engineering, life sciences, and technology while operating under the tenet of bringing innovative products and services to a complex new world. As consumers, businesses, and governments look for some type of normalcy, Dalrada’s subsidiaries are responding with alternative solutions that are affordable, available, accessible, and impactful.
For more information on Dalrada and its subsidiaries, visit www.dalrada.com.
About Dalrada (DFCO)
With perseverance, valor, dedication, and vision,
Dalrada is a global company that operates under the tenet of creating impactful innovations that matter for the world. The Company works continually to produce disruptive solutions that bridge the gap of accessibility and accelerate positive change for current and future generations.
Established in 1982, the Company has since grown its footprint to include the business divisions:
Disclaimer
Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors and will be dependent upon a variety of factors including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20210916005826/en/
858.283.1253
inquiries@dalrada.com
Source:
FAQ
What is Dalrada Corporation's stock symbol?
What COVID-19 testing services did Dalrada provide at the Boise Pride Festival?
Who partnered with Dalrada for COVID-19 testing?
What types of COVID-19 tests did Pala Diagnostics offer?